Effectiveness and safety of biologic and targeted synthetic disease-modifying anti-rheumatic drugs in elderly patients with rheumatoid arthritis: real-world data from the KOBIO Registry

Koh J. H.; Lee S-K; Kim J.; Kim H-A; Shin K.; Min J-K

首页> 外文期刊>Clinical and experimental rheumatology >Effectiveness and safety of biologic and targeted synthetic disease-modifying anti-rheumatic drugs in elderly patients with rheumatoid arthritis: real-world data from the KOBIO Registry

【24h】

Effectiveness and safety of biologic and targeted synthetic disease-modifying anti-rheumatic drugs in elderly patients with rheumatoid arthritis: real-world data from the KOBIO Registry

机译：生物学和靶向综合疾病改性抗风湿药物在类风湿性关节炎患者中的抗风湿药物的有效性和安全性：来自Kobio登记处的真实数据

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Objective

机译：None

著录项

来源
《Clinical and experimental rheumatology》 |2021年第2期|共10页
作者
Koh J. H.; Lee S-K; Kim J.; Kim H-A; Shin K.; Min J-K;
展开▼
作者单位

Catholic Univ Korea Bucheon St Marys Hosp Dept Internal Med Div Rheumatol Coll Med Seoul South;

Seoul Metropolitan Govt Seoul Boramae Med Ctr Dept Internal Med Div Rheumatol Seoul South Korea;

Chungnam Natl Univ Dept Internal Med Div Rheumatol Coll Med Daejeon South Korea;

Ajou Univ Dept Rheumatol Sch Med Suwon South Korea;

Seoul Metropolitan Govt Seoul Boramae Med Ctr Dept Internal Med Div Rheumatol Seoul South Korea;

Catholic Univ Korea Bucheon St Marys Hosp Dept Internal Med Div Rheumatol Coll Med Seoul South;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类免疫性疾病;
关键词
rheumatoid arthritis; elderly; anti-rheumatic agents; treatment outcome;

机译：类风湿性关节炎;老年人;抗风湿剂;治疗结果;

相似文献

外文文献
中文文献
专利

1. Effect of sustained intensive therapy with disease modifying anti-rheumatic drugs in rheumatoid arthritis: a 5-year real-world consecutive study [J] . Yue-Ming Cai, Jing Xu, Lian-Jie Shi, 中华医学杂志（英文版） . 2020,第012期
2. Leflunomide, a new disease-modifying drug for treating active rheumatoid arthritis in methotrexate-controlled phase Ⅱ clinical trial [J] . 鲍春德, 陈顺乐, 顾越英, 中华医学杂志（英文版） . 2003,第008期
3. Cost-effectiveness of biologic compared with conventional synthetic disease-modifying anti-rheumatic drugs in patients with rheumatoid arthritis: a Register study [J] . Joensuu Jaana T., Aaltonen Kalle J., Aronen Pasi, Rheumatology . 2016,第10期

机译：登记研究研究了生物制剂与传统的合成疾病抗风湿药相比在类风湿关节炎中的成本效益
4. Cost-effectiveness of biologic compared with conventional synthetic disease-modifying anti-rheumatic drugs in patients with rheumatoid arthritis: a Register study [J] . Joensuu Jaana T., Aaltonen Kalle J., Aronen Pasi, Rheumatology . 2016,第10期

机译：与类风湿性关节炎患者的常规合成疾病改性抗风湿药物相比，生物学的成本效益：注册研究
5. Efficacy and safety of baricitinib for active rheumatoid arthritis in patients with an inadequate response to conventional synthetic or biological disease-modifying anti-rheumatic drugs: A meta-analysis of randomized controlled trials [J] . Wu Zhi-Peng, Zhang Pei, Bai Jian-Zhong, Experimental and therapeutic medicine . 2018,第3aPta2期

机译：患有常规合成或生物疾病改性抗风湿药物不足反应的患者活性类风湿性关节炎的疗效和安全性：随机对照试验的荟萃分析
6. Macrophage-targeted Drug Delivery System for the Treatment of Rheumatoid Arthritis [C] . Amanda Pentecost, Minju Kim, Sangmin Jeon, Society for Biomaterials annual meeting and exposition . 2017

机译：用于治疗类风湿性关节炎的巨噬细胞靶向药物递送系统
7. The Efficacy of Therapeutic Drug Monitoring of Rheumatoid Arthritis Patients on Infliximab [D] . Abolhosn, Rania. 2018

机译：类风湿性关节炎患者治疗药物监测对英夫利昔单抗的疗效
8. Efficacy and safety of baricitinib for active rheumatoid arthritis in patients with an inadequate response to conventional synthetic or biological disease-modifying anti-rheumatic drugs: A meta-analysis of randomized controlled trials [O] . Zhi-Peng Wu, Pei Zhang, Jian-Zhong Bai, -1

机译：对传统的合成或可改变生物疾病的抗风湿药反应不足的患者Baricitinib治疗活动性类风湿关节炎的疗效和安全性：一项随机对照试验的荟萃分析
9. THU0163 A DESCRIPTIVE ANALYSIS OF LONGITUDINAL CHANGES IN RELATIVE MARKET SHARE PROPORTIONS OF BIOLOGIC AND TARGETED SYNTHETIC DISEASE-MODIFYING ANTI-RHEUMATIC DRUGS FOR TREATMENT OF RHEUMATOID ARTHRITIS: DATA FROM THE OBRI DATABASE [O] . Elliot Hepworth, Mohammad Movahedi, Emmanouil Rampakakis, 2019

机译：THU0163对生物和靶向综合疾病改性抗风湿性药物的相对市场份额比例的纵向变化的描述性分析，用于治疗类风湿性关节炎：来自OBRI数据库的数据
10. Comparative Effectiveness of Drug Therapy for Rheumatoid Arthritis and Psoriatic Arthritis in Adults [R] . Donahue, K. E., Gartlehner, G., Jonas, D. E., 2007

机译：药物治疗对成人类风湿性关节炎和银屑病关节炎的疗效比较

Effectiveness and safety of biologic and targeted synthetic disease-modifying anti-rheumatic drugs in elderly patients with rheumatoid arthritis: real-world data from the KOBIO Registry

摘要

著录项

相似文献

相关主题

期刊订阅